Evidence map›Paper›PMID 26149051›Full record

ReviewJournal of thrombosis and haemostasis : JTH2015

Road blocks in making platelets for transfusion.

J N Thon, D A Medvetz, S M Karlsson, J E Italiano

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of thrombosis and haemostasis : JTH, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Human iPS Cells for Clinical Applications and Cellular Products.Handbook of experimental pharmacology · 2023
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. [Cultured platelets].Bulletin de l'Academie nationale de medecine · 2020
    Review
  9. [Novel platelet pharming using human induced pluripotent stem cells].Bulletin de l'Academie nationale de medecine · 2020
    Review
  10. Induction of differentiation of human stem cellsWorld journal of stem cells · 2019
    Review
  11. Using genome editing to engineer universal platelets.Emerging topics in life sciences · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. On the Way toFrontiers in medicine · 2018
    Review
  16. Article
  17. Article
  18. Review
  19. Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

J N ThonHematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
D A MedvetzHematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
S M KarlssonPlatelet BioGenesis, Chestnut Hill, MA, USA.
J E ItalianoHematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Platelet BioGenesis (United States) · USBrigham and Women's Hospital · USHarvard University · US

Funding

Boston Biomedical Innovation CenterU54HL119145 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLAN, DAVID E., LOSCALZO, JOSEPH · 2013 to 2021
$18.8M
Examination of the Final Stages of Platelet ProductionR00HL114719 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI THON, JONATHAN N · 2015 to 2017
$747k
Examination of the Final Stages of Platelet ProductionK99HL114719 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI THON, JONATHAN N · 2013 to 2014
$266k
NHLBI NIH HHS 1K99HL114719-01A1NHLBI NIH HHS K99 HL114719NHLBI NIH HHS R00 HL114719NHLBI NIH HHS U54 HL119145NHLBI NIH HHS U54HL119145
6 · The paper itself

Abstract

The production of laboratory-generated human platelets is necessary to meet present and future transfusion needs. This manuscript will identify and define the major roadblocks that must be overcome to make human platelet production possible for clinical use, and propose solutions necessary to accelerate development of laboratory-generated human platelets to market.

Indexed as

Platelet TransfusionThrombopoiesisBioreactorsBlood PlateletsCell Culture TechniquesCells, CulturedCellular ReprogrammingGene Expression Regulation, DevelopmentalHumansInduced Pluripotent Stem CellsMegakaryocytesPhenotypeStem Cell Nichebiomedical engineeringbioreactorshematopoietic stem cellsmegakaryocytesplatelets

Identifiers

PMID26149051
PMCPMC5565795
OpenAlexW1569443407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.